User:Mr. Ibrahem/Tesamorelin

Tesamorelin, sold under the brand name Egrifta, is a medication used to treat HIV-associated lipodystrophy. Specifically it is used for excess abdominal fat. It is given by injection under the skin.

Common side effects include joint pain, redness at the site of injection, and leg swelling. Other side effects may include allergic reactions and cancer. Use in pregnancy may harm the baby. It is a manufactured form of growth-hormone-releasing hormone (GHRH).

Tesamorelin was approved for medical use in the United States in 2010. It is not approved in Europe. In the United States it costs about 6,400 USD per month as of 2021.